Proportion of Older White Men Recommended for Osteoporosis Treatment
Author Information
Author(s): Donaldson Meghan G, Cawthon Peggy M, Lui Lily Y, Schousboe John T, Ensrud Kristine E, Taylor Brent C, Cauley Jane A, Hillier Teresa A, Dam Thuy T, Curtis Jeff R, Black Dennis M, Bauer Douglas C, Orwoll Eric S, Cummings Steven R
Primary Institution: San Francisco Coordinating Center, California Pacific Medical Center
Hypothesis
What proportion of older white men would be recommended for pharmacologic treatment based on the new NOF guidelines?
Conclusion
The study estimates that about one-third of older white men aged 65 and older would be recommended for drug treatment for osteoporosis under the new NOF guidelines.
Supporting Evidence
- 34% of US white men aged 65 years and older would be recommended for drug treatment.
- 49% of men aged 75 years and older would be recommended for treatment.
- Men in MrOS had higher femoral neck BMD values compared to those in NHANES III.
Takeaway
The new guidelines suggest that many older white men might need medicine to help with bone health, even if they don't have osteoporosis.
Methodology
Data from the Osteoporotic Fractures in Men Study (MrOS) was used to apply the NOF treatment guidelines and estimate the proportion of men recommended for treatment.
Potential Biases
The MrOS cohort may not represent the general population as it consists of community-dwelling volunteers who are generally healthier.
Limitations
The study may underestimate the proportion of men recommended for treatment as it only includes white men aged 65 and older and does not account for some treatment criteria.
Participant Demographics
Participants were community-dwelling white men aged 65 years and older.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website